Bhupendar Tayal, Nadeen N Faza, Duc T Nguyen, Maan Malahfji, Stephen Little, Mujtaba Saeed, Sachin S Goel, Ashrith Guha, Kinan Carlos El-Tallawi, Edward A Graviss, Dipan J Shah
{"title":"非缺血性心肌病患者继发性二尖瓣反流与右心室功能障碍的关系","authors":"Bhupendar Tayal, Nadeen N Faza, Duc T Nguyen, Maan Malahfji, Stephen Little, Mujtaba Saeed, Sachin S Goel, Ashrith Guha, Kinan Carlos El-Tallawi, Edward A Graviss, Dipan J Shah","doi":"10.1093/ehjci/jeae134","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>The association between secondary mitral regurgitation (MR) and right ventricular (RV) dysfunction in heart failure patients with non-ischaemic cardiomyopathy (NICM) is unclear. Hence, our objective was to study the association between secondary MR and the occurrence of RV dysfunction among patients with NICM using cardiac magnetic resonance (CMR).</p><p><strong>Methods and results: </strong>Patients with NICM were enrolled in a prospective observational registry between 2008 and 2019. CMR was used to quantify MR severity along with RV function. The RV dysfunction was defined as RV ejection fraction <45%. The outcome of the study was a composite event of all-cause death, heart transplantation, or left ventricular assist device implantation at follow-up. In the study cohort of 241 patients, RV dysfunction (RVEF < 45%) was present in 148 (61%). In comparison with patients without RV dysfunction, those with RV dysfunction had higher median MR volume {23 mL [interquartile range (IQR) 16-31 mL] vs. 18 mL (IQR 12-25 mL), P = 0.002} and MR fraction [33% (IQR 25-43%) vs. 22% (IQR 15-29%), P < 0.001]. Furthermore, secondary MR was independently associated with RV dysfunction: MR volume ≥ 24 mL (OR 3.21, 95% CI 1.26-8.15, P = 0.01) and MR fraction ≥ 30% (OR 5.46, 95% CI 2.23-13.35, P = 0.002). Increasing RVEF (every 1% increase) was independently associated with lower risk of adverse events (HR 0.98; 95% CI 0.95, 1.00; P = 0.047).</p><p><strong>Conclusion: </strong>In patients with NICM, the severity of secondary MR is associated with an increased prevalence of RV dysfunction. The RV dysfunction is not only associated with the severity of LV dysfunction but also with the severity of secondary MR.</p><p><strong>Clinical trial registration: </strong>https://clinicaltrials.gov/ct2/show/NCT04281823.</p>","PeriodicalId":12026,"journal":{"name":"European Heart Journal - Cardiovascular Imaging","volume":" ","pages":"1627-1635"},"PeriodicalIF":6.7000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of secondary mitral regurgitation and right ventricular dysfunction among patients with non-ischaemic cardiomyopathy.\",\"authors\":\"Bhupendar Tayal, Nadeen N Faza, Duc T Nguyen, Maan Malahfji, Stephen Little, Mujtaba Saeed, Sachin S Goel, Ashrith Guha, Kinan Carlos El-Tallawi, Edward A Graviss, Dipan J Shah\",\"doi\":\"10.1093/ehjci/jeae134\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>The association between secondary mitral regurgitation (MR) and right ventricular (RV) dysfunction in heart failure patients with non-ischaemic cardiomyopathy (NICM) is unclear. Hence, our objective was to study the association between secondary MR and the occurrence of RV dysfunction among patients with NICM using cardiac magnetic resonance (CMR).</p><p><strong>Methods and results: </strong>Patients with NICM were enrolled in a prospective observational registry between 2008 and 2019. CMR was used to quantify MR severity along with RV function. The RV dysfunction was defined as RV ejection fraction <45%. The outcome of the study was a composite event of all-cause death, heart transplantation, or left ventricular assist device implantation at follow-up. In the study cohort of 241 patients, RV dysfunction (RVEF < 45%) was present in 148 (61%). In comparison with patients without RV dysfunction, those with RV dysfunction had higher median MR volume {23 mL [interquartile range (IQR) 16-31 mL] vs. 18 mL (IQR 12-25 mL), P = 0.002} and MR fraction [33% (IQR 25-43%) vs. 22% (IQR 15-29%), P < 0.001]. Furthermore, secondary MR was independently associated with RV dysfunction: MR volume ≥ 24 mL (OR 3.21, 95% CI 1.26-8.15, P = 0.01) and MR fraction ≥ 30% (OR 5.46, 95% CI 2.23-13.35, P = 0.002). Increasing RVEF (every 1% increase) was independently associated with lower risk of adverse events (HR 0.98; 95% CI 0.95, 1.00; P = 0.047).</p><p><strong>Conclusion: </strong>In patients with NICM, the severity of secondary MR is associated with an increased prevalence of RV dysfunction. The RV dysfunction is not only associated with the severity of LV dysfunction but also with the severity of secondary MR.</p><p><strong>Clinical trial registration: </strong>https://clinicaltrials.gov/ct2/show/NCT04281823.</p>\",\"PeriodicalId\":12026,\"journal\":{\"name\":\"European Heart Journal - Cardiovascular Imaging\",\"volume\":\" \",\"pages\":\"1627-1635\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2024-11-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Heart Journal - Cardiovascular Imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ehjci/jeae134\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal - Cardiovascular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjci/jeae134","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Association of secondary mitral regurgitation and right ventricular dysfunction among patients with non-ischaemic cardiomyopathy.
Aims: The association between secondary mitral regurgitation (MR) and right ventricular (RV) dysfunction in heart failure patients with non-ischaemic cardiomyopathy (NICM) is unclear. Hence, our objective was to study the association between secondary MR and the occurrence of RV dysfunction among patients with NICM using cardiac magnetic resonance (CMR).
Methods and results: Patients with NICM were enrolled in a prospective observational registry between 2008 and 2019. CMR was used to quantify MR severity along with RV function. The RV dysfunction was defined as RV ejection fraction <45%. The outcome of the study was a composite event of all-cause death, heart transplantation, or left ventricular assist device implantation at follow-up. In the study cohort of 241 patients, RV dysfunction (RVEF < 45%) was present in 148 (61%). In comparison with patients without RV dysfunction, those with RV dysfunction had higher median MR volume {23 mL [interquartile range (IQR) 16-31 mL] vs. 18 mL (IQR 12-25 mL), P = 0.002} and MR fraction [33% (IQR 25-43%) vs. 22% (IQR 15-29%), P < 0.001]. Furthermore, secondary MR was independently associated with RV dysfunction: MR volume ≥ 24 mL (OR 3.21, 95% CI 1.26-8.15, P = 0.01) and MR fraction ≥ 30% (OR 5.46, 95% CI 2.23-13.35, P = 0.002). Increasing RVEF (every 1% increase) was independently associated with lower risk of adverse events (HR 0.98; 95% CI 0.95, 1.00; P = 0.047).
Conclusion: In patients with NICM, the severity of secondary MR is associated with an increased prevalence of RV dysfunction. The RV dysfunction is not only associated with the severity of LV dysfunction but also with the severity of secondary MR.
期刊介绍:
European Heart Journal – Cardiovascular Imaging is a monthly international peer reviewed journal dealing with Cardiovascular Imaging. It is an official publication of the European Association of Cardiovascular Imaging, a branch of the European Society of Cardiology.
The journal aims to publish the highest quality material, both scientific and clinical from all areas of cardiovascular imaging including echocardiography, magnetic resonance, computed tomography, nuclear and invasive imaging. A range of article types will be considered, including original research, reviews, editorials, image focus, letters and recommendation papers from relevant groups of the European Society of Cardiology. In addition it provides a forum for the exchange of information on all aspects of cardiovascular imaging.